Literature DB >> 8846231

Neutron activation analysis of trace elements in motor neuron disease spinal cord.

W R Markesbery1, W D Ehmann, J M Candy, P G Ince, P J Shaw, L Tandon, M A Deibel.   

Abstract

Levels of 10 trace elements were analysed in autopsied lumbar spinal cords of 38 motor neuron disease patients and 22 control subjects using instrumental neutron activation analysis. Statistically significant elevations of iron, selenium and zinc, and depletions of mercury and cesium were found in the spinal cords of motor neuron disease patients compared with control subjects. No significant correlations were found between disease duration, clinical severity or lumbar motor neuron counts and iron and selenium levels, suggesting that accumulation of these elements occur early as well as late in the disease process and therefore are not a consequence of end stage pathology. Increased iron in motor neuron disease spinal cord could act to enhance formation of reactive oxygen species. Our study supports the free radical hypothesis of neuron degeneration in motor neuron disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8846231     DOI: 10.1006/neur.1995.0046

Source DB:  PubMed          Journal:  Neurodegeneration        ISSN: 1055-8330


  9 in total

1.  Amyotrophic lateral sclerosis, enteral nutrition and the risk of iron overload.

Authors:  Alessio Molfino; Irma Kushta; Valentina Tommasi; Filippo Rossi Fanelli; Maurizio Muscaritoli
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

2.  Implementation of X-ray fluorescence microscopy for investigation of elemental abnormalities in amyotrophic lateral sclerosis.

Authors:  B Tomik; J Chwiej; M Szczerbowska-Boruchowska; M Lankosz; S Wójcik; D Adamek; G Falkenberg; S Bohic; A Simionovici; Z Stegowski; A Szczudlik
Journal:  Neurochem Res       Date:  2006-05-03       Impact factor: 3.996

Review 3.  Glutamate, excitotoxicity and amyotrophic lateral sclerosis.

Authors:  P J Shaw; P G Ince
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

4.  Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice.

Authors:  Herman L Lelie; Amir Liba; Megan W Bourassa; Madhuri Chattopadhyay; Pik K Chan; Edith B Gralla; Lisa M Miller; David R Borchelt; Joan Selverstone Valentine; Julian P Whitelegge
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

5.  Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients.

Authors:  E F Goodall; M S Haque; K E Morrison
Journal:  J Neurol       Date:  2008-07-18       Impact factor: 4.849

6.  Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.

Authors:  Marco Vinceti; Nikolay Solovyev; Jessica Mandrioli; Catherine M Crespi; Francesca Bonvicini; Elisa Arcolin; Eleni Georgoulopoulou; Bernhard Michalke
Journal:  Neurotoxicology       Date:  2013-05-31       Impact factor: 4.294

Review 7.  Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review.

Authors:  Sahar Sheykhansari; Kristen Kozielski; Joachim Bill; Metin Sitti; Donato Gemmati; Paolo Zamboni; Ajay Vikram Singh
Journal:  Cell Death Dis       Date:  2018-03-01       Impact factor: 8.469

Review 8.  A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk.

Authors:  Diane B Re; Beizhan Yan; Lilian Calderón-Garcidueñas; Angeline S Andrew; Maeve Tischbein; Elijah W Stommel
Journal:  J Neurol       Date:  2022-01-01       Impact factor: 6.682

Review 9.  The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light.

Authors:  Joanna F Collingwood; Mark R Davidson
Journal:  Front Pharmacol       Date:  2014-08-19       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.